Zoetis Inc.’s Stock Price Stumbles, Falling to $165.89 with a -2.05% Change: Is Now the Time to Buy?

Zoetis Inc. (ZTS)

165.89 USD -3.48 (-2.05%) Volume: 4.65M

Zoetis Inc.’s stock price stands at 165.89 USD, experiencing a trading session dip of -2.05%, with a trading volume of 4.65M. Despite the dip, the stock has maintained a positive YTD change of +3.03%, showcasing its resilience in the market.

Latest developments on Zoetis Inc.

Zoetis, a leading player in the Companion Animal Diagnostic Services market, has been in the spotlight recently. Yarbrough Capital LLC and Carnegie Investment Counsel have both decreased their stakes in Zoetis Inc., while Outlook Wealth Advisors LLC and Fiduciary Financial Group LLC have increased their holdings. Brokerages have set a price target of $211.89 for Zoetis stock, with Leerink Partners estimating the company’s FY2024 earnings. StrongBox Wealth LLC, CCLA Investment Management, and Assenagon Asset Management S.A. have all made significant moves in acquiring Zoetis shares. Meanwhile, Campbell Newman Asset Management Inc. and Moseley Investment Management Inc. have reduced their stakes in the company. With these key events leading up to today, investors are closely watching Zoetis’ quarterly earnings preview to gauge the stock price movements.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Zoetis has an overall positive outlook for the long term. With moderate scores in Value, Growth, Resilience, and Momentum, and a slightly higher score in Dividend, the company seems to be in a stable position. Zoetis focuses on discovering, developing, and commercializing animal health medicines and vaccines for both livestock and companion animals, with a global market presence across various regions.

Zoetis’s Smart Scores suggest that the company is well-positioned for future growth and stability in the animal health industry. While there is room for improvement in certain areas such as Value and Resilience, the company’s strong scores in Dividend and Momentum indicate a positive trajectory. With a diverse market presence in regions across the world, Zoetis seems poised to continue its success in providing essential healthcare solutions for animals.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma